LifeSci Shareholders Approve Vincera Merger

LifeSCi Acquisition in an 8-K filing said shareholders voted in favor of the business combination with Vincera Pharma.

The combined company is expected to have approximately $62 million in cash at closing, which Vincera reported today. Shares begin trading Dec. 24 on the Nasdaq under VINC. Read more.

Total
0
Shares
Related Posts
Ares Acquisition
Read More

Ares Closes Upsized $1B IPO

The SPAC has said it will not be limited to a particular industry or geographic region in its identification and acquisition of a target company, except that it does not intend to pursue the fossil fuel energy industry.